The Indian Ayurveda industry sector, which has a gross market size of Rs. 30,000 crore, has witnessed 50 to 90 per cent growth during the last few months with major players seeing big jump in their sales. At the same time, a new trend in marketing of different products, especially of proprietary medicines, has emerged.
Usually, there happens only 20% growth every year, but this extraordinary increase in the sales of Ayurveda products that happened in the first quarter of this financial year is unique, said Vaidya Rajesh Kotecha, secretary, Ministry of Ayush.
He was delivering the inaugural speech in an international zoom meeting organized by the Rosenberg European Academy of Ayurveda (REAA) in Frankfurt in Germany with participation of Ayurveda practitioners from across the world.
According to him, major manufactures like Himalayas and Dabur have achieved big growth in their sales, especially in the marketing of ‘Rasayanas’ like Chyawanaprasha and in wellness products. Chyawanaprasha has been proposed by Ayush ministry as an immunity booster. Ayush ministry has initiated clinical studies and prophylactic studies on various Ayurveda products and medicinal properties like ‘Aswagandha’ to fight against the COVID pandemic through ayurvedic intervention. Two studies on ‘Chyawanaprasha’ and three studies on ‘Aswagandha’ have been completed and the results show positive signs. All the studies and researches have shown that Ayurveda preparations are efficacious to treat asymptomatic and those patients with mild and moderate symptoms.
The ministry has issued guidelines based on scientific evidence for COVID management through Ayush interventions which include yoga and meditation also. With the help of various state governments Ayush has given prophylactic care to millions of people. Several Ayush infrastructure and human resources have been identified to fight against the pandemic.
Associating with health workers of all spheres, the ministry of Ayush has created an inter-governmental platform for training Ayush professionals in COVID management. A total of 832,445 volunteers have been selected for voluntary services and 727 educational institutions have been made available for use as centres for COVID treatment and for quarantine and isolation facilities. In addition to this, various Ayush hospitals have been converted as COVID treatment centres.
While speaking, Kotecha said in the area of research in COVID management through Ayurveda, the ministry of Ayush is encouraging research activities in three areas, ie, public health research, clinical research and in marketing of products. Before entering into clinical research, it already did the pre-clinical research using the tools in-vivo and in-vitro studies.
Further, the Ayush secretary reminded that this is the first time such rigorous scientific studies have been planned for Ayush streams to get proper medicines to tackle virus diseases. About three lakh subjects have been registered in clinical trials of ayurvedic drugs on 53 centers and 91 clinical trial projects. This is a mega project and findings from these projects will be evaluated by scientists of the Indian Council of Medical Research (ICMR), Council of Scientific Industrial Research (CSIR) and all others before publishing and claiming any positive or other results. He said initial results are encouraging and establishing the wisdom of the Indian traditional knowledge to manage any kind of pandemic.
Prof Anand Chaudhary, HoD of Rasashastra and Bhasihjya Kalpana (Ayurvedic Pharmaceutics ) at the Institute of Medical Sciences, Banaras Hindu University in Varanasi, spoke on “impact of doshaa on ancient ayurvedic dosage forms and its relevance on the invention of new ayurvedic dosage forms“ as part of the webinar. Dr Ram Manohar, principal of School of Ayurveda under Amrita University in Kerala, Prof S N Gupta from Gujarat JSS Ayurvedic Institutes, Prof Tanuja Nesari Director, All Indian Institute of Ayurveda, New Delhi, and Prof Abhimanyu Kumar Vice-Chancellor, SSR Ayurveda University, Jodhpur were the other participants from India.
Mark Rosenberg and Kerstein Rosenberg, the directors of the REAA moderated the seminar.
Source : 1